The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    La Thangue, Nicholas Barrie, Prof
    Director born in November 1957
    Individual (8 offsprings)
    Officer
    2010-05-24 ~ now
    OF - director → CIF 0
  • 2
    Lee, Bungkwn
    Director born in April 1960
    Individual (1 offspring)
    Officer
    2019-09-10 ~ now
    OF - director → CIF 0
  • 3
    Kerr, David James, Professor
    Company Director born in June 1956
    Individual (6 offsprings)
    Officer
    2024-04-17 ~ now
    OF - director → CIF 0
  • 4
    Jamal, Mohammed
    Director born in January 1980
    Individual (33 offsprings)
    Officer
    2023-03-31 ~ now
    OF - director → CIF 0
Ceased 20
  • 1
    Slagel, Dean Marc
    Managing Director Investments born in March 1970
    Individual (3 offsprings)
    Officer
    2015-12-16 ~ 2023-11-22
    OF - director → CIF 0
  • 2
    Macdonald, Alasdair
    Company Lawyer born in June 1959
    Individual (10 offsprings)
    Officer
    2015-01-27 ~ 2017-05-05
    OF - director → CIF 0
  • 3
    Cheon, Se-young
    Director born in October 1963
    Individual
    Officer
    2019-05-29 ~ 2021-03-09
    OF - director → CIF 0
  • 4
    Browning, David
    Chief Executive Officer born in February 1963
    Individual (5 offsprings)
    Officer
    2017-10-09 ~ 2019-07-19
    OF - director → CIF 0
  • 5
    Lee, Baeckseung, Dr
    Director born in December 1969
    Individual
    Officer
    2019-06-11 ~ 2022-01-25
    OF - director → CIF 0
  • 6
    Mortimer, Michael
    Executive Vice President born in April 1960
    Individual (6 offsprings)
    Officer
    2012-01-30 ~ 2015-01-21
    OF - director → CIF 0
  • 7
    Oxlade, David Aufere
    Company Director born in May 1949
    Individual
    Officer
    2013-01-15 ~ 2020-01-08
    OF - director → CIF 0
  • 8
    Otter, James Anthony
    Director born in November 1957
    Individual (10 offsprings)
    Officer
    2019-07-01 ~ 2020-01-13
    OF - director → CIF 0
  • 9
    Park, Sang Tae
    Chief Executive born in April 1973
    Individual (2 offsprings)
    Officer
    2022-01-25 ~ 2023-03-31
    OF - director → CIF 0
  • 10
    Frohn, Matthew Gerard Winston, Dr
    Partner born in February 1967
    Individual (22 offsprings)
    Officer
    2015-12-16 ~ 2020-01-07
    OF - director → CIF 0
  • 11
    Boman, Erik Anders
    Director born in November 1963
    Individual (2 offsprings)
    Officer
    2018-04-17 ~ 2019-04-30
    OF - director → CIF 0
  • 12
    Towler, Christopher Malcolm, Dr
    Company Director born in July 1949
    Individual (1 offspring)
    Officer
    2019-06-11 ~ 2023-05-16
    OF - director → CIF 0
  • 13
    Lee, Kyoung Mee, Dr
    Director born in April 1969
    Individual
    Officer
    2021-04-22 ~ 2024-04-23
    OF - director → CIF 0
  • 14
    Cons, Ben Major George, Dr
    Scientist born in March 1966
    Individual (1 offspring)
    Officer
    2012-01-30 ~ 2015-12-16
    OF - director → CIF 0
  • 15
    Zhang, Hao, Dr
    Chief Executive born in September 1979
    Individual (3 offsprings)
    Officer
    2021-07-20 ~ 2022-05-20
    OF - director → CIF 0
  • 16
    Kerr, David James, Prof
    Scientist born in June 1956
    Individual (6 offsprings)
    Officer
    2010-05-24 ~ 2011-02-18
    OF - director → CIF 0
    Kerr, David James, Prof
    Director born in June 1956
    Individual (6 offsprings)
    2011-08-02 ~ 2023-03-31
    OF - director → CIF 0
  • 17
    Smart, Joanna
    Commercial Director born in April 1979
    Individual (7 offsprings)
    Officer
    2021-12-14 ~ 2023-09-13
    OF - director → CIF 0
  • 18
    Edwards, Glyn Owain
    Director born in June 1955
    Individual (3 offsprings)
    Officer
    2011-12-01 ~ 2012-04-30
    OF - director → CIF 0
  • 19
    Kim, Hyungtae, Dr
    Director born in February 1963
    Individual
    Officer
    2017-06-27 ~ 2017-12-31
    OF - director → CIF 0
  • 20
    Mccooke, Nicholas John
    Chief Executive Officer born in July 1953
    Individual (1 offspring)
    Officer
    2012-07-26 ~ 2013-11-01
    OF - director → CIF 0
parent relation
Company in focus

OXFORD CANCER BIOMARKERS LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Property, Plant & Equipment
69,673 GBP2023-12-31
11,155 GBP2022-12-31
Total Inventories
29,012 GBP2023-12-31
29,012 GBP2022-12-31
Debtors
Current
285,831 GBP2023-12-31
445,539 GBP2022-12-31
Cash at bank and in hand
138,318 GBP2023-12-31
79,320 GBP2022-12-31
Current Assets
453,161 GBP2023-12-31
553,871 GBP2022-12-31
Net Current Assets/Liabilities
-106,925 GBP2023-12-31
-80,278 GBP2022-12-31
Net Assets/Liabilities
-37,252 GBP2023-12-31
-69,123 GBP2022-12-31
Average Number of Employees
82023-01-01 ~ 2023-12-31
112022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Other
15,750 GBP2023-12-31
15,750 GBP2022-12-31
Intangible Assets - Gross Cost
15,750 GBP2023-12-31
15,750 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
15,750 GBP2023-12-31
15,750 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
4,865 GBP2023-12-31
6,022 GBP2022-12-31
Office equipment
37,163 GBP2023-12-31
35,422 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
122,028 GBP2023-12-31
41,444 GBP2022-12-31
Property, Plant & Equipment - Disposals
Furniture and fittings
-1,157 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Disposals
-1,157 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
80,000 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
4,865 GBP2023-12-31
5,938 GBP2022-12-31
Office equipment
30,823 GBP2023-12-31
24,351 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
52,355 GBP2023-12-31
30,289 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
84 GBP2023-01-01 ~ 2023-12-31
Plant and equipment
16,667 GBP2023-01-01 ~ 2023-12-31
Office equipment
6,472 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
23,223 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Furniture and fittings
-1,157 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-1,157 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
16,667 GBP2023-12-31
Property, Plant & Equipment
Plant and equipment
63,333 GBP2023-12-31
Office equipment
6,340 GBP2023-12-31
11,071 GBP2022-12-31
Furniture and fittings
84 GBP2022-12-31
Raw materials and consumables
29,012 GBP2023-12-31
29,012 GBP2022-12-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
27,556 GBP2022-12-31
Other Debtors
Current, Amounts falling due within one year
231,561 GBP2023-12-31
293,000 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
285,831 GBP2023-12-31
445,539 GBP2022-12-31
Total Borrowings
Current, Amounts falling due within one year
131,457 GBP2023-12-31
351,509 GBP2022-12-31
Other Remaining Borrowings
Current
131,457 GBP2023-12-31
Total Borrowings
Current
131,457 GBP2023-12-31
351,509 GBP2022-12-31
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
13,164 shares2023-12-31
13,158 shares2022-12-31
Par Value of Share
Class 2 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
640 shares2023-12-31
640 shares2022-12-31
Par Value of Share
Class 3 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
400 shares2023-12-31
400 shares2022-12-31
Par Value of Share
Class 4 ordinary share
12023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
679 shares2023-12-31
Number of Shares Issued (Fully Paid)
14,883 shares2023-12-31
14,198 shares2022-12-31
Nominal value of allotted share capital
14,883 GBP2023-01-01 ~ 2023-12-31
14,198 GBP2022-01-01 ~ 2022-12-31
  • OXFORD CANCER BIOMARKERS LIMITED
    Info
    Registered number SC379069
    C/o Douglas Mcdonald Ca, 2 Octavia Buildings, Kilmacolm PA13 4AE
    Private Limited Company incorporated on 2010-05-24 (15 years). The company status is Active.
    The last date of confirmation statement was made at 2024-12-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.